Yilu Wang

No. 168 Litang Road
Changping, 102218, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Novel DES cardiomyopathy presenting with lifelong syncope: diagnostic breakthrough via multimodal imaging and insertable cardiac monitor.

Novel DES cardiomyopathy presenting with lifelong syncope: diagnostic breakthrough via multimodal imaging and insertable cardiac monitor.

Journal: European heart journal

Published: September 19, 2025

Prognostic value of cardiac fibroblast activation heterogeneity assessed by FAPI PET radiomics in hypertrophic cardiomyopathy: a proof-of-concept study.

Prognostic value of cardiac fibroblast activation heterogeneity assessed by FAPI PET radiomics in hypertrophic cardiomyopathy: a proof-of-concept study.

Journal: Open heart

Published: July 01, 2025

Fulminant Myocarditis Secondary to Cardiac T-Cell Lymphoma.

Fulminant Myocarditis Secondary to Cardiac T-Cell Lymphoma.

Journal: JACC. Case reports

Published: April 07, 2025

Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.

Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: February 04, 2017

Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.

Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.

Journal: International journal of cardiology

Published: December 07, 2016

Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.

Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.

Journal: The Canadian journal of cardiology

Published: October 19, 2014

Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.

Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.

Journal: European journal of heart failure

Published: June 04, 2014

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

Journal: Journal of cellular and molecular medicine

Published: April 09, 2014

Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.

Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.

Journal: International journal of molecular sciences

Published: March 07, 2014

Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.

Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.

Journal: PloS one

Published: January 21, 2014

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.

Journal: PloS one

Published: March 10, 2013

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.

Journal: Molecular biology reports

Published: August 10, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026